Market Access, Regulatory and Clinical Trial Experts in Europe
Pharma Design is a small service provider with a network of specialised consultants.
Core Services
- Strategic and Regulatory advice
- Marketing Applications, Scientific Advice, Paediatric Advice
- Orphan Designation
- Paediatric Plan and PDCO interaction
- Clinical Trial Design and CTA submission (EU, UK, Switzerland, Israel)
- Clinical Safety & Pharmacovigilance (DSUR, PSUR, RMP submission)
- Establishment of European subsidiaries, legal entities, headquarters, management teams
Our Services Are Highly Competitive
Pharmacovigilance
Our PV services covering your products in Europe, including EU, UK, Switzerland.
Regulatory Consulting
Choose our Regulatory Affairs strategic services for your products or have our specialised consultants outsourced to your team.
Market Access
Let us help you establish legal entity in Europe and prepare for Market Launch.
Recent Articles
-
Navigating ATMP Marketing Authorisation Applications in Europe
As specialists in regulatory affairs for pharmaceutical developers, particularly those outside the EU, Pharma Design Limited has extensive experience guiding clients through the complexities of…
-
MHRA Signals Major Overhaul of Rare Disease Regulatory Framework: Faster Paths to UK Approval in 2026
On 2 November 2025, MHRA published a pivotal position paper outlining a comprehensive overhaul of the regulatory framework for rare disease therapies in the UK.…
News and Updates
-
The Cost-Effectiveness of Pharma Design Limited: A Practical Alternative to Traditional CROs for European Regulatory Support
In the competitive landscape of pharmaceutical development, regulatory affairs play a pivotal role in bringing innovative therapies to market. For developers, particularly those based outside…